http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 17 Apr 2025 07:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html <p align="left">SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors.</p> <p>“It is a pleasure to welcome John to our Board,” said Fredrik Wiklund, Chief Executive Officer of Bright Peak Therapeutics. “John brings decades of experience and an extensive track record of success in the biotech sector. His strategic insights and financial expertise will be instrumental as we advance our clinical http://www.streetinsider.com/Press+Releases/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html Thu, 17 Apr 2025 07:00:00 -0400 ANAB DSGN HLXA PSTX XERS http://www.streetinsider.com/Press+Releases/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html <p align="left">SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors.</p> <p>“It is a pleasure to welcome John to our Board,” said Fredrik Wiklund, Chief Executive Officer of Bright Peak Therapeutics. “John brings decades of experience and an extensive track record of success in the biotech sector. His strategic insights and financial expertise will be instrumental as we advance our clinical http://www.streetinsider.com/Press+Releases/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html Thu, 17 Apr 2025 07:00:00 -0400 ANAB DSGN HLXA PSTX XERS http://www.streetinsider.com/Press+Releases/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html <p align="left">SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors.</p> <p>“It is a pleasure to welcome John to our Board,” said Fredrik Wiklund, Chief Executive Officer of Bright Peak Therapeutics. “John brings decades of experience and an extensive track record of success in the biotech sector. His strategic insights and financial expertise will be instrumental as we advance our clinical http://www.streetinsider.com/Press+Releases/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html Thu, 17 Apr 2025 07:00:00 -0400 ANAB DSGN HLXA PSTX XERS http://www.streetinsider.com/Press+Releases/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html <p align="left">SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors.</p> <p>“It is a pleasure to welcome John to our Board,” said Fredrik Wiklund, Chief Executive Officer of Bright Peak Therapeutics. “John brings decades of experience and an extensive track record of success in the biotech sector. His strategic insights and financial expertise will be instrumental as we advance our clinical http://www.streetinsider.com/Press+Releases/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html Thu, 17 Apr 2025 07:00:00 -0400 ANAB DSGN HLXA PSTX XERS http://www.streetinsider.com/Press+Releases/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html <p align="left">SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors.</p> <p>“It is a pleasure to welcome John to our Board,” said Fredrik Wiklund, Chief Executive Officer of Bright Peak Therapeutics. “John brings decades of experience and an extensive track record of success in the biotech sector. His strategic insights and financial expertise will be instrumental as we advance our clinical http://www.streetinsider.com/Press+Releases/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html Thu, 17 Apr 2025 07:00:00 -0400 ANAB DSGN HLXA PSTX XERS http://www.streetinsider.com/Globe+Newswire/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html <p align="left">SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors.</p> <p>“It is a pleasure to welcome John to our Board,” said Fredrik Wiklund, Chief Executive Officer of Bright Peak Therapeutics. “John brings decades of experience and an extensive track record of success in the biotech sector. His strategic insights and financial expertise will be instrumental as we advance our clinical http://www.streetinsider.com/Globe+Newswire/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html Thu, 17 Apr 2025 07:00:00 -0400 ANAB DSGN HLXA PSTX XERS http://www.streetinsider.com/Globe+Newswire/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html <p align="left">SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors.</p> <p>“It is a pleasure to welcome John to our Board,” said Fredrik Wiklund, Chief Executive Officer of Bright Peak Therapeutics. “John brings decades of experience and an extensive track record of success in the biotech sector. His strategic insights and financial expertise will be instrumental as we advance our clinical http://www.streetinsider.com/Globe+Newswire/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html Thu, 17 Apr 2025 07:00:00 -0400 ANAB DSGN HLXA PSTX XERS http://www.streetinsider.com/Globe+Newswire/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html <p align="left">SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors.</p> <p>“It is a pleasure to welcome John to our Board,” said Fredrik Wiklund, Chief Executive Officer of Bright Peak Therapeutics. “John brings decades of experience and an extensive track record of success in the biotech sector. His strategic insights and financial expertise will be instrumental as we advance our clinical http://www.streetinsider.com/Globe+Newswire/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html Thu, 17 Apr 2025 07:00:00 -0400 ANAB DSGN HLXA PSTX XERS http://www.streetinsider.com/Globe+Newswire/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html <p align="left">SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors.</p> <p>“It is a pleasure to welcome John to our Board,” said Fredrik Wiklund, Chief Executive Officer of Bright Peak Therapeutics. “John brings decades of experience and an extensive track record of success in the biotech sector. His strategic insights and financial expertise will be instrumental as we advance our clinical http://www.streetinsider.com/Globe+Newswire/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html Thu, 17 Apr 2025 07:00:00 -0400 ANAB DSGN HLXA PSTX XERS http://www.streetinsider.com/Globe+Newswire/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html <p align="left">SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors.</p> <p>“It is a pleasure to welcome John to our Board,” said Fredrik Wiklund, Chief Executive Officer of Bright Peak Therapeutics. “John brings decades of experience and an extensive track record of success in the biotech sector. His strategic insights and financial expertise will be instrumental as we advance our clinical http://www.streetinsider.com/Globe+Newswire/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html Thu, 17 Apr 2025 07:00:00 -0400 ANAB DSGN HLXA PSTX XERS